跳至主要内容
临床试验/NCT04874584
NCT04874584已完成不适用

Utilizing a Culturally Tailored Nurse Coaching Intervention to Decrease Symptom Severity and Prevent Dehydration in Patients With Metastatic Cancer

University of Miami2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2021年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
Incidents of dehydration

研究概览

简要总结

The purpose of the study is to see whether or not a telephone/ text message intervention, delivered by a registered nurse, is helpful in managing symptoms and can also prevent dehydration caused by chemotherapy treatment when given together for patients with metastatic breast, colon, lung or prostate cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible for Chemotherapy for the first time (Previous & Ongoing hormonal only treatment allowed OR Neoadjuvant & Adjuvant chemotherapy regimens with 2+ drugs allowed)
  • > 18 years old
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-
  • There are no life expectancy restrictions
  • Women of child-bearing potential are allowed in the study as long as they are eligible for the chemotherapy treatment.
  • Ability to understand and the willingness to sign a written informed consent document.

排除标准

  • Patients on immunotherapy only will be excluded
  • Previous chemotherapy
  • Under 18 years old
  • Medically Diagnosed with a Cognitive Impairment. Rationale for excluding people with cognitive impairment is that they would not be able to fully participate in the self-management care aspects of the intervention via the telephone, nor provide informed consent.
  • No access to a telephone
  • Blind or Deaf; If subject is Hearing-impaired or illiterate, then the subject may have a family member participate as a telecommunication surrogate with them in the study

结局指标

主要结局

Incidents of dehydration

时间窗: up to 12 weeks

Incidents of unscheduled medical visits for IV hydration

Change in MDASI scores

时间窗: baseline, up to 12 weeks

MD Anderson Symptom Inventory (MDASI) is a 19 item scale with a score range from 0-10 per symptom question that measures symptom severity plus symptom interference combined to measure total symptom burden. The higher score indicates worsening of symptoms.

次要结局

  • change in Partners in Health Scale (PIHS) scores(baseline, up to 12 weeks)
  • Change in FACT-C Scores(baseline, up to 12 weeks)
  • change in Chronic Disease Self-Efficacy Scale (CDSES) scores(baseline, up to 12 weeks)
  • Change in FACT-B Scores(baseline, up to 12 weeks)
  • Change in FACT-P Scores(baseline, up to 12 weeks)
  • Change in FACT-LC Scores(baseline, up to 12 weeks)
  • Percentage of completed call or text message(up to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Natasha Solle, PhD, RN

assistant research professor

University of Miami

研究点 (2)

Loading locations...

相似试验